AI assistant
Sending…
Cartesian Therapeutics, Inc. — Director's Dealing 2016
Jun 22, 2016
33483_dirs_2016-06-21_7d356c93-d715-4814-ba04-74f0649c6b83.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-06-21
Reporting Person: HUTT PETER BARTON (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $8.97 | 2024-04-22 | Common Stock (20512) | Direct | |
| Stock Option (right to buy) | $0.47 | 2020-03-07 | Common Stock (24358) | Direct |
Footnotes
F1: This option vests in 48 substantially equal monthly installments beginning on March 9, 2014.
F2: All shares underlying the option are fully vested.
More from Cartesian Therapeutics, Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Mar 30
Major Shareholding Notification
2026
Feb 5
Regulatory Filings
2026
Jan 9
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8